* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Inside Dental Assisting
Dental degree wikipedia , lookup
Scaling and root planing wikipedia , lookup
Dental hygienist wikipedia , lookup
Sjögren syndrome wikipedia , lookup
Periodontal disease wikipedia , lookup
Oral cancer wikipedia , lookup
Dental emergency wikipedia , lookup
Tooth decay wikipedia , lookup
that can assist in the appraisal of the health status or risk for a multitude of patientsâ health conditions. These tests enable clinicians to identify patients whose genetic susceptibility to periodontal disease may put them at increased risk. This genetic testing for the interleukin-1 (IL-1) gene cluster, a significant inflammatory mediator, complements other periodontal screening procedures and other salivary bacterial DNA testing that can be performed for specific oral pathogens. Saliva analysis can also be used as a non-invasive screening tool to identify the type(s) of oral human papilloma virus (HPV) present in the oral cavity. Studies have identified several high-risk strains of HPVâespecially the variants HPV-16 and HPV-18âas potential etiologic agents in the development of squamous cell carcinoma of the head and neck (SCCHN).1,2 This increased knowledge enables the clinician to discuss the potential risk of SCCHN with the patient and determine the appropriate referral and monitoring recommendations. Cytology, the harvesting of disaggregated cells and related microscopic material, may be used as either a field of view or site-specific assessment tool. A clinician may be able to obtain a considerable amount of information on the patientâs health status, depending on the collection method, transport mechanisms used, and tests requested. Cytology may yield important screening information when the patient has health issues that may preclude performing a surgical biopsy or other procedures at that time. Liquid-based cytology of the oral cavity is a relatively new, FDA-approved screening technique. The procedure involves a minimally invasive collection of transepithelial mucosa cells and other microbiology with a nylon bristle brush, with minimal or no discomfort to the patient. The collected material and brush are then placed into a special liquid preservative/fixative bottled solution for transportation to the laboratory for processing and evaluation. With liquid cytology, the clinician can request tests for several generalized oral conditions such as herpes simplex infection and candidiasis. Liquid-based and conventional transepithelial cytology smears, which are often referred to as a "brush test" or the OralCDx® (OralScan Laboratories Inc, www.sopreventable.com) are most commonly used to assess specific areas that have been detected with other screening methods. The brush test is frequently used on suspicious leukoplakia or erythroplakia areas, to aid in determining the presence or lack of a potential dysplastic change. In this role, cytology is an extremely valuable modality used to evaluate an area of concern for dysplasia, a potentially malignant condition. Cytology assists in helping to determine if an immediate invasive full-thickness biopsy procedure should be performed, or if the area should be closely monitored. Cytology is not a substitute for the traditional, "gold standard" surgical biopsy technique that removes architecturally intact tissue for histological evaluation. The only accepted method of diagnosing an oral cancer is a surgical biopsy with a microscopic examination, performed by an oral pathologist to evaluate all of the available information.